A comprehensive inquiry into this phenomenon was recently undertaken by a team at Kyoto University in collaboration with Arthur D. Little Japan. Harnessing the power of bibliometric analysis, the group meticulously examined over 160,000 scholarly articles published between 1989 and 2023, sourced from PubMed and OpenAlex databases. This extensive dataset provided an unprecedented vantage point to track the evolution of CGT research trends and to assess the contributions from major global players. Static numbers alone, however, were insufficient to fully characterize the dynamics of this field, which prompted a closer qualitative evaluation alongside quantitative metrics.

The findings brought to light a dual narrative of progress and stagnation. Hematopoietic stem cell transplantation (HSCT), including the prevalent bone marrow transplantation technique, along with ex vivo gene therapies—where genetic modifications occur outside the patient’s body before reinfusion—have shown consistent and robust growth. These areas have steadily moved closer to widespread clinical application, supported by a growing corpus of scientific literature and translational breakthroughs. In stark contrast, mesenchymal stem cell therapy and in vivo gene therapy, which involve direct administration to combat inflammation and facilitate genetic alteration inside the body respectively, have struggled to achieve comparable momentum in clinical adoption.

An intriguing geographic disparity emerged when the researchers delved into regional publication trends. Japan, despite its long-standing expertise in regenerative medicine, contributes a substantial volume of research papers on cell therapy. However, these works often lack the decisive qualitative impact necessary to drive global standards or influence clinical guidelines significantly. Conversely, the United States and China dominate the field—not only by the sheer number of publications but also through the production of high-impact studies that frequently serve as reference points for future innovations. Importantly, many of these influential works bear the hallmark of international collaboration, underscoring the synergistic value of cross-border research partnerships.

The notion that collaboration begets impact was crystallized by team leader Sumimasa Nagai, who highlighted the robust ties binding Europe and the United States as well as notable academic networks within Europe itself. These collaborative networks function as innovation ecosystems, enabling the fusion of diverse expertise, shared resources, and novel investigative approaches that collectively fuel scientific breakthroughs. Nonetheless, geopolitical shifts and fluctuations in research funding—particularly in the United States—pose uncertain challenges to these well-established collaborative frameworks, potentially reshaping the future landscape of CGT innovation.

From a methodological perspective, the Kyoto team’s bibliometric approach represents a critical advancement in understanding the trajectory of CGT. By integrating data analytics with domain-specific expertise, the study offers a nuanced map of progress that moves beyond traditional literature reviews. This analytical lens facilitates the identification of not only prolific research clusters but also emerging subfields and underexplored therapeutic avenues. Such insights can guide strategic decisions by policymakers, funding agencies, and academic institutions aiming to optimize the allocation of research resources and streamline the pathway from bench to bedside.

Beyond the realm of pure publication metrics, the team acknowledges the necessity of incorporating supplementary dimensions such as patent landscapes, regulatory frameworks, and financial investment trends. These factors critically influence the translation of scientific discoveries into viable therapies accessible to patients. Therefore, future research efforts are set to expand the analytical framework, adapting multi-layered data integration to holistically capture the complete innovation lifecycle in regenerative medicine, including CGT.

Japan’s unique position in this global mosaic is pivotal. With its strong foundational capabilities in cell biology and regenerative science, the country is poised to move beyond academic production and into impactful societal implementation. The current study lays the groundwork for this strategic transition, aiming to consolidate Japan’s strengths and foster synergistic collaborations that amplify both scientific and clinical outcomes. Realizing these ambitions will require concerted efforts to elevate research quality, enhance international partnerships, and navigate complex regulatory pathways.

While progress in CGT heralds transformative potential for patients suffering from conditions once deemed intractable, the uneven advancements evidenced by this bibliometric analysis serve as a clarion call for sustained, coordinated action. Advancing cell and gene therapy from experimental phases into mainstream medicine hinges on bridging divides—whether they be technological, geographic, or institutional. The lessons gleaned from this extensive research underscore that innovation thrives where diverse minds converge and where infrastructure and policy environments support rather than hinder scientific exploration.

As the field marches forward, the integration of new technologies such as CRISPR-based genome editing, advanced cell manufacturing techniques, and artificial intelligence-driven analytics promises to accelerate discovery and application. These emerging tools dovetail perfectly with the existing momentum in ex vivo gene therapies and hematopoietic transplantation, potentially expanding therapeutic frontiers and unraveling new disease mechanisms. However, addressing the stagnation in other CGT domains will require nuanced approaches tailored to biological, clinical, and regulatory complexities unique to those therapies.

In summation, this landmark bibliometric study paints a detailed picture of the past 35 years of CGT research, illuminating patterns of growth, identifying regional strengths and weaknesses, and advocating for enhanced international collaboration. The outcomes not only chronicle scientific progress but also chart a strategic course for future endeavors, emphasizing that the intersection of robust data analytics and interdisciplinary cooperation is indispensable to turning cellular and genetic therapies into universal standards of care. With the foundations firmly established, the coming decades hold promise for CGT to fulfill its transformative promise in medicine.

Subject of Research: Cells

Article Title: Advancement in Cell and Gene Therapy Research: a 35-Year Bibliometric Perspective

News Publication Date: 10-Jan-2026

Web References:
http://dx.doi.org/10.1016/j.jcyt.2026.102056

References:
Advancement in Cell and Gene Therapy Research: a 35-Year Bibliometric Perspective. Cytotherapy. 10 January 2026. DOI: 10.1016/j.jcyt.2026.102056

Image Credits:
Yuki Kitahara and Sumimasa Nagai

Keywords:
Gene therapy, Medical treatments, Clinical medicine, Bibliometrics, Impact factors, Scientific collaboration

Employing advanced bibliometric and visualization techniques, this study offers a panoramic view of the scholarly landscape, dissecting patterns of publication, citation networks, and emerging research fronts. Such an integrative approach not only delineates the maturation of scientific inquiry into the neonatal gut microbiome’s role in NEC but also sheds light on prevailing research hotspots and gaps. This comprehensive analysis underscores the dynamic interplay between microbial ecology and neonatal gastrointestinal health—pointing toward new conceptual frameworks and potential therapeutic avenues.

The investigation reveals a marked escalation in the volume of publications beginning in the early 2000s, coinciding with technological leaps in next-generation sequencing and metagenomics. These innovations have revolutionized our ability to characterize complex microbial communities with unprecedented precision, dispelling previous limitations associated with culture-based methods. This surge reflects a growing consensus within the scientific community regarding the gut microbiome’s pivotal role in NEC development. Additionally, citation trends indicate influential studies that have shaped prevailing hypotheses and informed experimental models, reinforcing the interdependence of empirical data and theoretical advancements.

At the thematic core of this bibliometric study is the recognition of distinct clusters of research focusing on specific microbial taxa, host-microbe interactions, and immune responses that either exacerbate or mitigate NEC severity. Of particular note are repeated findings implicating disruptions in bacterial phyla such as Firmicutes and Proteobacteria, which frequently dominate dysbiotic neonatal guts preceding NEC onset. The study’s visualization mapping elegantly captures these thematic nodes, illustrating how investigative foci have diverged and converged over time, guiding the research community toward nuanced understandings of microbial contributions.

Moreover, this analysis emphasizes the burgeoning interest in probiotic interventions aimed at restoring a balanced microbial milieu. Clinical trials evaluating the efficacy and safety of specific probiotic strains have proliferated, paralleled by mechanistic studies elucidating how these microbes influence gut barrier integrity, inflammatory cascades, and pathogen exclusion. The bibliometric data suggest that this translational research is accelerating, a hopeful beacon toward potential preventive strategies for NEC.

The research landscape is further characterized by a growing interdisciplinary dimension, integrating insights from neonatology, microbiology, immunology, and computational biology. This integrative approach is essential for unraveling the multilayered complexity of the neonatal gut ecosystem and its vulnerabilities. The study identifies key contributing authors, institutions, and geographic regions, highlighting centers of excellence that function as hubs for collaborative innovation. Such mapping not only fosters scholarly connectivity but also democratizes access to cutting-edge knowledge across international boundaries.

Intriguingly, the temporal analysis reveals shifts in methodological preferences, reflecting evolving technological capabilities and analytical paradigms. Early reliance on 16S rRNA gene sequencing has progressively been augmented by metatranscriptomics, metabolomics, and multi-omics integration. This progression enables a holistic appreciation of microbial function, metabolic outputs, and host responses, moving beyond descriptive community profiling toward mechanistic elucidation. The bibliometric visualization vividly captures this transition, symbolizing the maturation of the field.

One cannot overlook the role that animal models have played in this investigative journey. While human data remain paramount, the ethical and logistical complexities inherent in neonatal research necessitate the use of murine and other models to experimentally manipulate microbial communities and immune pathways. The bibliometric analysis reflects a steady presence of such preclinical studies, underscoring their vital contribution to hypothesis testing and therapeutic validation.

The study additionally sheds light on the evolution of funding patterns and publication platforms, which have collectively nurtured the growth of microbiota-NEC research. Open-access initiatives and multidisciplinary journals have proliferated, facilitating wider dissemination of findings and stimulating discourse. The bibliometric data underscore the importance of well-supported research infrastructures and the value of transparent data sharing to accelerate collective progress.

Future directions elucidated by this analysis call for intensified efforts to decode the temporal dynamics of gut colonization in neonates, the impact of perinatal factors such as antibiotic exposure and feeding practices, and the identification of reliable microbial biomarkers for early NEC prediction. Such endeavors require sophisticated longitudinal study designs and integrative computational models capable of distilling complex datasets into actionable clinical insights.

The pressing need to translate these research advancements into tangible clinical protocols is also evident. Personalized medicine approaches that harness microbiome data for risk stratification and tailored interventions represent a promising frontier. The bibliometric trends suggest a gradual pivot toward precision neonatology, where microbial profiling could one day be routine in neonatal intensive care units, optimizing outcomes for the most vulnerable infants.

In conclusion, this pioneering bibliometric and visualization analysis marks a significant milestone in our collective understanding of the neonatal gut microbiota’s role in necrotizing enterocolitis. It provides a structural blueprint of past achievements and future opportunities, reinforcing the premise that microbial ecosystems within neonatal patients are not merely passengers but potent determinants of health and disease. The integration of systems biology with clinical practice promises to redefine NEC management in the coming years, transforming a devastating condition into one that is increasingly preventable and treatable.

As researchers and clinicians continue to unravel the complexities of microbial-host interactions in the fragile neonatal gut, this comprehensive mapping serves as both a testament to scientific progress and a clarion call for sustained innovation. The battle against NEC is far from over, but armed with these insights, the medical community is better equipped than ever to tilt the balance toward neonatal survival and wellbeing, catalyzing a new era of microbiome-informed neonatal care.

Subject of Research: Gut microbiota and necrotizing enterocolitis (NEC) in neonates

Article Title: Gut microbiota in necrotizing enterocolitis: a bibliometric and visualization analysis

Article References:
Pei, Q., Zhang, M., Lei, M. et al. Gut microbiota in necrotizing enterocolitis: a bibliometric and visualization analysis. Pediatr Res (2025). https://doi.org/10.1038/s41390-025-04495-y

Image Credits: AI Generated

DOI: 03 December 2025